ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANIP ANI Pharmaceuticals Inc

62.00
-0.19 (-0.31%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ANI Pharmaceuticals Inc NASDAQ:ANIP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.19 -0.31% 62.00 61.91 62.05 62.50 61.06 62.50 82,825 22:30:00

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

29/05/2024 9:30pm

GlobeNewswire Inc.


ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart


From May 2024 to Jul 2024

Click Here for more ANI Pharmaceuticals Charts.

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows:

Date:June 5, 2024
  
Time:4:30 ET
  
Webcast:Click Here
  

To schedule a 1x1 meeting with the Company, please contact your Jefferies representative.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset Purified Cortrophin® Gel, strengthening its Generics business with enhanced research and development capabilities, delivering innovation in Established Brands, and leveraging its U.S. based manufacturing footprint. For more information, please visit our website www.anipharmaceuticals.com.

Investor Relations: Lisa M. Wilson, In-Site Communications, Inc.

T: 212-452-2793 E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

1 Year ANI Pharmaceuticals Chart

1 Year ANI Pharmaceuticals Chart

1 Month ANI Pharmaceuticals Chart

1 Month ANI Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock